Role of adjuvant narrow band ultraviolet B phototherapy in the treatment of chronic urticaria

8Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Chronic urticaria is a common dermatological disorder that causes a great deal of distress in patients and affects daily life. Narrow band ultraviolet B (NBUVB) has been shown to be an effective treatment in chronic urticaria in few studies. However, the data regarding its role in chronic urticaria are limited. Aims and Objectives: The aim of this study was to determine the role of NBUVB in the treatment of chronic urticaria in combination with antihistamine. Materials and Methods: A total of 80 patients of chronic urticaria were recruited, out of which 40 were allocated to NBUVB-loratadine group and 40 to loratadine group. Patients were assessed using urticaria activity score (UAS) at same point of time, i.e. after 4 weeks (8 sessions), 8 weeks (16 sessions) and at follow up of 4 weeks after stopping the treatment. Results: On comparing the two groups, the mean UAS was significantly lower after 8 and 16 sessions in NBUVB-loratadine group (12.03 v/s 21.43 and 3.54 v/s 17.16, respectively). The difference in reduction of UAS7 in two groups was seen to be statistically significant (P value < 0.01). Conclusion: Thus we conclude that NBUVB may be useful in the treatment of chronic urticaria.

Cite

CITATION STYLE

APA

Sheikh, G., Latif, I., Lone, K., Hassan, I., Jabeen, Y., & Keen, A. (2019). Role of adjuvant narrow band ultraviolet B phototherapy in the treatment of chronic urticaria. Indian Journal of Dermatology, 64(3), 250. https://doi.org/10.4103/ijd.IJD_475_16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free